Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional Study (VAC-M)
This study aims to investigate vaccine-related knowledge, attitude, vaccine confidence and vaccine hesitancy among MSM across multiple countries and regions.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Huachun Zou
- Número de telefone: +86-21-54237707
- E-mail: zouhuachun@fudan.edu.cn
Estude backup de contato
- Nome: Feiyang Yin
- Número de telefone: +86 18008631217
- E-mail: fyyin25@m.fudan.edu.cn
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Self-identify as MSM, with eligibility in certain participating countries and regions potentially extended to transgender women and non-binary individuals who have sexual relations with men, using the same questionnaire.
Descrição
Inclusion Criteria:
-
Participants will be eligible for the study if they meet all of the following conditions:
- Have resided in a participating country or region for at least six months.
- Are aged 18 years or older.
- Self-identify as MSM, with eligibility in certain participating countries and regions potentially extended to transgender women and non-binary individuals who have sexual relations with men, using the same questionnaire.
Exclusion Criteria:
-
Participants will be excluded if they meet any of the following conditions:
- Are aged under 18 years.
- Decline to participate in the study or fail to complete the informed consent process.
- Have not resided, or do not currently reside, in a participating country or region.
- Submit duplicate responses from the same IP address or device.
- Fail data quality checks, including automated or fraudulent submissions and failure to pass human verification procedures.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: CASE_ONLY
- Perspectivas de Tempo: CROSS_SECTIONAL
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Homens que fazem sexo com homens
|
No interventions because it is a observational cross-sectional study |
|
transgender women and non-binary individuals
transgender women and non-binary individuals who have sexual relations with men |
No interventions because it is a observational cross-sectional study |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Vaccine uptake
Prazo: Baseline, at enrollment in this cross-sectional study
|
Percentage(%) of participants who have received at least one dose of HPV vaccine, assessed by self-reported vaccination history |
Baseline, at enrollment in this cross-sectional study
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Vaccine knowledge
Prazo: Baseline, at enrollment in this cross-sectional study
|
Vaccine knowledge will be measured based on participants' scores on the vaccine knowledge items included in the study questionnaire, which will assess general vaccine knowledge and HPV vaccine-specific knowledge. Responses to individual items will be scored according to the predefined scoring criteria and summed to generate domain-specific knowledge scores. Higher scores indicate greater knowledge in the corresponding domain. |
Baseline, at enrollment in this cross-sectional study
|
|
Vaccine attitude
Prazo: Baseline, at enrollment in this cross-sectional study
|
Vaccine attitudes will be measured based on participants' scores on the Vaccination Attitudes Examination Scale included in the study questionnaire, which assesses four dimensions of vaccination attitudes: mistrust of vaccine benefits, worries about unforeseen future effects, concerns about commercial profiteering, and preference for natural immunity. Responses to individual items will be scored according to the predefined scoring criteria and combined to generate an overall vaccine attitude score. Higher scores indicate more negative attitudes toward vaccination. |
Baseline, at enrollment in this cross-sectional study
|
|
Vaccine confidence
Prazo: Baseline, at enrollment in this cross-sectional study
|
Vaccine confidence will be measured based on participants' scores on the Vaccine Confidence Index included in the study questionnaire, which assesses perceptions of vaccine importance, safety, effectiveness, and compatibility with religious beliefs. Responses to individual items will be scored according to the predefined scoring criteria and combined to generate an overall vaccine confidence score. Higher scores indicate greater confidence in vaccines. |
Baseline, at enrollment in this cross-sectional study
|
|
Vaccine hesitancy
Prazo: Baseline, at enrollment in this cross-sectional study
|
Vaccine hesitancy will be measured based on participants' scores on the Vaccine Hesitancy Scale included in the study questionnaire. The scale assesses participants' perceptions of vaccine importance and effectiveness, trust in vaccine information and recommendations, perceived benefits of vaccination, and concerns about vaccine risks and adverse effects. Responses to individual items will be scored according to the predefined scoring criteria and summed to generate a total vaccine hesitancy score. Higher total scores indicate greater vaccine hesitancy. |
Baseline, at enrollment in this cross-sectional study
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- H2026163
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .